NL-OMON32694已完成4 期
The influence of omeprazole and pantoprazole on the platelet reactivity and inhibition of platelet aggregration of clopidogrel. - The influence of omeprazole and pantoprazole on the activity of clopidogrel
Atrium Medisch Centrum0 个研究点目标入组 27 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 27
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Use of clopidogrel and aspirin or carbasalate calcium.
- •2. Use of omeprazole as prophylaxis against NSAID induced gastric damage.
- •3. Written informed consent.
- •4. 18 years or older.
排除标准
- •1. Use of medication which affects the metabolism of clopidogrel
- •2. Severe adverse reaction or hypersensitivity reaction to pantoprazole.
- •3. Gastrointesnital ulcer.
- •5. Renal impairment (creatinine> 200 mmol/l).
- •6. liver disease (AST, ALT, GGT> 3 x ULN).
- •7. Pregnancy
研究者
相似试验
已完成
不适用
Comparison of the effect of Omeprazole, Pantoprazole and Esomeprazole in treatment of laryngopharyngeal refluxIRCT2017050133277N2Vice Chancellor for Research, Tehran University of Medical Science60
已完成
4 期
Comparison of the Effect of Omeprazole,Pantoprazole,Esomeprazole and Lansoprazole on the Patients with Gastroesophageal Reflux DiseaseIRCT20171007036616N1Abidi Pharma120
尚未招募
不适用
The comparison of the efficacy of two therapeutic regimens in the treatment of gastroesophageal reflux disease in term neonates.IRCT20160827029535N10Tehran University of Medical Sciences120
已完成
2 期
Herbal drug for treatment of Gastro-esophageal reflux diseaseGastro-oesophageal reflux disease.Gastro-oesophageal reflux diseaseIRCT2016072129026N1Hormozgan Science & Technology Park60
已完成
2 期
Herbal Drug for Treatment of Functional Dyspepsia.Functional dyspepsia.DyspepsiaIRCT2016072629026N2Hormozgan Science & Technology Park60